Calls for Proposals Overseas FY 2022 Advanced Research and Development Programs for Medical Innovation (AMED-CREST, PRIME)

Change log

7th July, 2022
"Interview Selection Meeting" have been updated.

16th May, 2022
"Interview Selection Meeting", "Recording of Public invitation briefing", "Proposal Forms", and "Application Guidelines" have been updated.

Outline

Status of Grants/Funding Opportunities Grants/Funding Opportunities
R&D phase Basic Study
Key Fields Innovation and Clinical Research Center Project
Submission Deadline 05/31/22 Tue Noon (Japan standard time) No exceptions for delay
Contact
Division of Innovative Research and Development, Department of Innovation and Clinical Research Center
E-mail: kenkyuk-kobo “AT”amed.go.jp (Please replace “AT” with “@”)
Remarks:
Please contact us by e-mail using the above contact information.

Public offering content

Bridging the fundamental mechanism of aging and the effective treatment of age-related disease associated with impaired functional system

Program Supervisor (PS): MOCHIZUKI Naoki, Director General, National Cerebral and Cardiovascular Center

Program Officer (PO): FUKAMIZU Akiyoshi, Director, Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance, University of Tsukuba

Program Officer (PO): YASUTOMO Koji, Professor, Graduate School of Medical Sciences, Tokushima University

This R&D area aims to clarify the biology of the basic mechanisms involved in aging and to develop medical approaches mediated via these mechanisms. The programs will include research that uses the most up-to-date analytical technologies (genetic, imaging, omics analysis) and can be progressed from analysis in model organisms through to applied research. This R&D area will be implemented by AMED and JST together, with the two organizations liaising closely to promote the research.

Immunological memory: Understanding, regulation and medical innovation

Program Supervisor (PS): NAKAYAMA Toshinori, President, Chiba University

Program Officer (PO): TAKEDA Kiyoshi, Professor, Graduate School of Medicine, Osaka University

We welcome R&D proposals that will contribute to: (1) a new and fundamental understanding of how human immunological memory is formed, maintained, and lost; (2) clarification of novel mechanisms of cancer immunity mediated by human immunological memory; (3) an understanding of human immunological memory against infectious diseases in societies living with COVID-19 and after the COVID-19 pandemic; and (4) development of novel methods controlling allergic and autoimmune diseases, based on an understanding of human immunological memory.

Integrated understanding of multi-sensing networks and elucidation of their control mechanisms leading to the innovation of medical technologies

Program Supervisor (PS): NAGAI Ryozo, President, Jichi Medical University

Program Officer (PO): TAKEUCHI Shoji, Professor, Graduate School of Information Science and Technology, the University of Tokyo

Program Officer (PO): NISHIDA Kohji, Professor, Graduate School of Medicine, Osaka University

This R&D area aims to develop an integrated understanding of multi-sensory systems that includes sensory systems and peripheral nerve networks, and create innovative seeds for medical technologies based on an understanding of control mechanisms. This R&D area is implemented by AMED and JST together, with the two organizations liaising closely to promote the research. 

Generating research infrastructure and novel technologies for anti-infective drug and vaccine discovery

Program Supervisor (PS): DOI Yohei, Professor, Departments of Microbiology and Infectious Diseases, Fujita Health University School of Medicine / Professor, Division of Infectious Diseases, University of Pittsburgh School of Medicine

Program Officer (PO): MATSUURA Yoshiharu, Director, Center for Infectious Diseases Education and Research (CiDER) and SA Professor, Laboratory of Virus Control, Research Institute for Microbial Diseases (RIMD), Osaka University

We call for research proposals in the following specific areas: (1) develop new approaches, including drug discovery modalities, that will contribute to the prevention and treatment of infectious diseases; (2) optimize existing modalities for infectious disease drug discovery; and (3) develop technology platforms that will accelerate infectious disease drug discovery and generate innovative preventive and therapeutic agents against infectious diseases.

Understanding proteostasis and discovering innovative medical applications

Program Supervisor (PS): NAGATA Kazuhiro, Director General, JT Biohistory Research Hall

Program Officer (PO): ENDO Tamao, Senior Fellow, Tokyo Metropolitan Institute of Gerontology

We invite proposals for innovative basic research that takes a transdisciplinary approach with the goal of understanding protein denaturation, regeneration, aggregation, and degradation processes, in terms of an understanding of normal maturation processes and the relationship with disease.

Solicitation Period

04/12/22 Tue - 05/31/22 Tue Noon (Japan standard time) No exceptions for delay

Interview Schedule

Interview Selection Meeting

Please confirm the details as indicated below. Only eligible participants will be notified it via an e-mail by a week before the interview.
Please understand we will not answer any questions regarding the selections and interviews.
※Interview reviews will be conducted over the Internet.

Research and Development Area AMED-CREST PRIME
Bridging the fundamental mechanism of aging and the effective treatment of age-related disease associated with impaired functional system August 11th
August 12th
August 3th
August 4th
August 5th
Immunological memory: Understanding, regulation and medical innovation August 9th We are not offering it.
Integrated understanding of multi-sensing networks and elucidation of their control mechanisms leading to the innovation of medical technologies

August 10th

August 6th
August 7th

Generating research infrastructure and novel technologies for anti-infective drug and vaccine discovery August 9th We are not offering it.
Understanding proteostasis and discovering innovative medical applications August 8th August 9th
August 10th

Public invitation briefing

Recording of Public invitation briefing

Contents Briefing materials
Explanation of general rules of the program

-

Bridging the fundamental mechanism of aging and the effective treatment of age-related disease associated with impaired functional system Japanese  version only
Immunological memory: Understanding, regulation and medical innovation Download
Integrated understanding of multi-sensing networks and elucidation of their control mechanisms leading to the innovation of medical technologies Download
Generating research infrastructure and novel technologies for anti-infective drug and vaccine discovery Download
Understanding proteostasis and discovering innovative medical applications Download

How to Apply

Proposal Forms

Research and Development Area AMED-CREST PRIME
All R&D areas Proposal Form E1
Proposal Form E2
Appendix E1
Appendix E2
Appendix E3

※Appendix E2 should be submitted in Excel format.
※Appendix E3 must be submitted in Excel format, if your research plan includes whole human genome analysis and/or whole exome analysis.
Proposal From P1
Appendix P1
Appendix P2
 
※Appendix P2 must be submitted in Excel format, if your research plan includes whole human genome analysis and/or whole exome analysis.

Reference

04/12/22

Last updated 07/07/22